Survival studies of 51Cr Ch(a+) red blood cells in a patient with anti-Cha, and massive transfusion of incompatible blood.
Survival studies of 51Cr, Ch(a+) red blood cells in a patient with anti-Cha, showed normal survival time in the observation period of 6 days. Successive massive transfusion of Ch(a+) blood was performed without any complication. A very strong secondary immune response to the Ch antigen was observed.